Stocks To Buy Right Now 2017 🔥 Original

Small-to-mid cap biotechs saw astronomical gains; Madrigal Pharmaceuticals (MDGL) rose 516% , while Sangamo Therapeutics (SGMO) gained 438% . The Losers:

Corporate profits re-accelerated after two years of stagnation. stocks to buy right now 2017

“Basically, as Square's customers grow, so does Square's top line. And lately, so has SQ stock.” Cabot Wealth Network Small-to-mid cap biotechs saw astronomical gains

+95% (Consumer Discretionary) – Benefited from a recovery in the Macau gambling market. Madrigal Pharmaceuticals (MDGL) rose 516%

Hit multi-decade lows, reflecting a remarkably steady upward march. Top 10 S&P 500 Performers of 2017

A high-profile laggard, dropping 44.8% during the year. Under Armour (UAA): Plummeted over 50% . Why the Market Surged